Bi(6-TG)3 for COVID-19

Bi(6-TG)3 has been reported as potentially beneficial for COVID-19 in the following study.

COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed Bi(6-TG)3 in detail.

Study suggesting benefit with Bi(6-TG)3

Wei et al., Mechanistic insights into bismuth(iii) inhibition of SARS-CoV-2 helicase, Chemical Science, doi:10.1039/d3sc06961c

Helicase(nsp13) is an important target of bismuth-based antivirals by metal-tagged antibody-based approach.